Phagenesis Appoints Chad Hoskins as Chief Executive Officer Following Recent Close of $42M Series D Financing

Contributed by: PR Newswire

Images

PR Newswire associated0

PR Newswire associated1

Tags

Phagenesis

More Like This

Phagenesis, a medical device company specializing in the treatment of swallowing disorders, successfully closes a $42M Series D financing round led by EQT Life Sciences and Sectoral Asset Management

Chad Swanson, Ph.D., Chief Development Officer, Prothena (Photo: Business Wire)

Prothena Announces Leadership Team Updates

Epsilogen Appoints Ashley Nagle as Chief Business Officer and Peter Finan as Non-Executive Chairman as Part of Broader Company Expansion

PR Newswire associated0

EXPANSE MEDICAL WELCOMES JEFF HOPKINS AS CEO AND BOARD MEMBER OF ITS SPIN-OFF, FLOWPHYSIX

Mark Pugh Appointed New CEO of Theragenics Corporation (Photo: Business Wire)

Mark Pugh Appointed CEO of Theragenics Corporation

Zenas BioPharma Strengthens Executive Leadership with Appointment of Jennifer Fox as Chief Business Officer and Chief Financial Officer and Tanya Fischer, M.D., PhD. as Head of R&D and Chief Medical Officer

PR Newswire associated0

NeoChord, Inc. Appoints New Chief Executive Officer to Lead Commercialization Efforts and Study Novel First-Line Therapy for Mitral Valve Regurgitation

David Ford, Chief People Officer, Prothena (Photo: Business Wire)

Prothena Appoints David Ford to Newly Created Chief People Officer Position